Ftse Mib
38.752,85
0,73%
DAX
22.438,20
0,08%
S&P 500
5.931,38
-0,87%
NASDAQ
19.020,29
-1,38%
Bitcoin
86.816,82
-5,06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Marinus Pharmaceuticals Inc (MRNS) Marinus Pharmaceuticals Inc (MRNS) Notizie

MRNS

Marinus Pharmaceuticals (MRNS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MRNS
DataOraFonteTitoloSimboloCompagnia
21/02/202514:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:MRNSMarinus Pharmaceuticals Inc
14/02/202522:30Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
14/02/202506:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/02/202502:45Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/02/202515:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/02/202515:05Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/02/202514:55Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/02/202514:49Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MRNSMarinus Pharmaceuticals Inc
11/02/202514:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
07/02/202513:10Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
07/02/202513:01Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
08/01/202522:41Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:MRNSMarinus Pharmaceuticals Inc
02/01/202521:25Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202413:11Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202413:00Business WireImmedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.NASDAQ:MRNSMarinus Pharmaceuticals Inc
10/12/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
15/11/202400:39Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
14/11/202421:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
12/11/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNSMarinus Pharmaceuticals Inc
12/11/202422:00Business WireMarinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
24/10/202414:00Business WireMarinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic AlternativesNASDAQ:MRNSMarinus Pharmaceuticals Inc
17/10/202413:00Business WireMarinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
15/10/202422:00Business WireMarinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration RegimensNASDAQ:MRNSMarinus Pharmaceuticals Inc
09/10/202413:00Business WireMarinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
08/10/202422:04Business WireMarinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:MRNSMarinus Pharmaceuticals Inc
20/09/202414:00Business WireMarinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst DayNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/09/202414:00Business WireMarinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
10/09/202414:00Business WireMarinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:MRNSMarinus Pharmaceuticals Inc
19/08/202414:00Business WireMarinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
13/08/202413:00Business WireMarinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MRNS

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
LDO
Leonardo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
PRY
Prysmian
BIT
BAMI
Banco BPM
BIT
MONC
Moncler
BIT
FCT
Fincantieri
BIT
RACE
Ferrari NV
BIT
NEXI
Nexi S.p.A
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci